New bone graft shows promise for neck surgery patients

NCT ID NCT02814825

Completed Disease control Sponsor: DePuy Spine Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study looked at how well ViviGen, a bone graft made from donated human bone cells, helps fuse neck bones in people having 2- or 3-level neck surgery. 100 patients were followed to see if their bones fused and how their pain and function improved. The goal was to gather real-world data on this already-approved product.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: ViviGen cellular bone matrix (a bone graft material made from donated human bone cells and tissue)
What this could lead to: If successful, this could confirm that ViviGen helps neck bones fuse together better after surgery, potentially improving recovery and reducing pain.
What could go wrong: This is a small, single-arm study with no comparison group, so results may not prove ViviGen is better than other bone graft materials. Fusion success also depends on many factors beyond the graft.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CERVICAL SPONDYLOSIS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Intervertebral Disc Displacement intervertebral disk degenerative disorder lumbar disk degenerative disorder spondylosis spondylosis, cervical

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

CERVICAL SPONDYLOSIS DEGENERATIVE INTERVERTEBRAL DISCS HERNIATED DISC

More trials for these conditions

Other studies related to the condition(s) this trial covers.